TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/24/24 19:04 | 6/20/24 | WGS | Genedx Holdings Corp. | DE | Health | Health | Health Services | Casdin Eli | CT | DT | M.d | 0 | 0.00 | 0 | 6 | 0 | 3,867 | D | |||||||||||||||
5/19/23 21:02 | 5/17/23 | LAB | Standard Biotools Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Casdin Eli | NY | DT | P.m | 2,631 | 2.19 | 0 | 1,200 | 999% | 1,247 | I | |||||||||||||||
5/4/23 16:04 | 5/2/23 | WGS | Genedx Holdings Corp. | DE | Health | Health | Health Services | Casdin Eli | CT | D | M.d | 0 | 0.00 | 0 | 45 | 0 | 113,204 | D | |||||||||||||||
2/2/23 16:05 | 1/31/23 | WGS | Genedx Holdings Corp. | DE | Health | Health | Health Services | Casdin Eli | CT | DT | P | 30,000 | 0.3500 | 0 | 85,714 | 312 | 113,158 | I | |||||||||||||||
11/25/22 19:05 | 11/17/22 | TNYA | Tenaya Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Casdin Eli | NY | D | P.d | 6,479 | 2.60 | 0 | 2,492 | 69 | 6,079 | I | |||||||||||||||
5/12/22 20:20 | 4/27/22 | SMFR | Sema4 Holdings Corp. | DE | Health | Health | Health Services | Casdin Eli | CT | D | M.d | 0 | 0.00 | 0 | 13 | New | 13 | D | |||||||||||||||
5/3/22 16:01 | 4/29/22 | SMFR | Sema4 Holdings Corp. | DE | Health | Health | Health Services | Casdin Eli | CT | D | P | 45,750 | 4.00 | 0 | 11,438 | 72 | 27,431 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |